Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Benavides

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Revista Medica De Chile|August 31, 2007
[Surgical treatment of gastric cancer: results in 423 cases]Carlos C García, Carlos C Benavides, Sergio P Apablaza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Results of the first phase I clinical trial of the novel II-key hybrid preventive HER-2/neu peptide (AE37) vaccineJarrod P Holmes, Linda C Benavides, Jeremy D Gates, et al.
Cancer|October 28, 2016
Results of a randomized controlled trial to increase cervical cancer screening among rural LatinasBeti Thompson, Elizabeth A Carosso, Esther Jhingan, et al.
Cancer Immunology, Immunotherapy : CII|April 9, 2008
Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02Asna Amin, Linda C Benavides, Jarrod P Holmes, et al.
Vaccine|September 23, 2010
Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptideJeremy D Gates, Guy T Clifton, Linda C Benavides, et al.
Expert Opinion on Biological Therapy|September 8, 2011
AE37: a novel T-cell-eliciting vaccine for breast cancerAlan K Sears, Sonia A Perez, Guy T Clifton, et al.
The Journal of Trauma and Acute Care Surgery|May 31, 2023
Committee on Surgical Combat Casualty Care position statement: Neurosurgical capability for the optimal management of traumatic brain injury during deployed operationsJennifer M Gurney, Matthew D Tadlock, Bradley A Dengler, et al.
Global Change Biology|September 9, 2020
Belowground impacts of alpine woody encroachment are determined by plant traits, local climate, and soil conditionsCourtney G Collins, Marko J Spasojevic, Concepción L Alados, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 12, 2018
Correction: "Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 10 affected individuals"Kai Lee Yap, Amy E Knight Johnson, David Fischer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 17, 2018
Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 9 affected individualsKai Lee Yap, Amy E Knight Johnson, David Fischer, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Revista Medica De Chile|August 31, 2007
[Surgical treatment of gastric cancer: results in 423 cases]Carlos C García, Carlos C Benavides, Sergio P Apablaza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Results of the first phase I clinical trial of the novel II-key hybrid preventive HER-2/neu peptide (AE37) vaccineJarrod P Holmes, Linda C Benavides, Jeremy D Gates, et al.
Cancer|October 28, 2016
Results of a randomized controlled trial to increase cervical cancer screening among rural LatinasBeti Thompson, Elizabeth A Carosso, Esther Jhingan, et al.
Cancer Immunology, Immunotherapy : CII|April 9, 2008
Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02Asna Amin, Linda C Benavides, Jarrod P Holmes, et al.
Vaccine|September 23, 2010
Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptideJeremy D Gates, Guy T Clifton, Linda C Benavides, et al.
Expert Opinion on Biological Therapy|September 8, 2011
AE37: a novel T-cell-eliciting vaccine for breast cancerAlan K Sears, Sonia A Perez, Guy T Clifton, et al.
The Journal of Trauma and Acute Care Surgery|May 31, 2023
Committee on Surgical Combat Casualty Care position statement: Neurosurgical capability for the optimal management of traumatic brain injury during deployed operationsJennifer M Gurney, Matthew D Tadlock, Bradley A Dengler, et al.
Global Change Biology|September 9, 2020
Belowground impacts of alpine woody encroachment are determined by plant traits, local climate, and soil conditionsCourtney G Collins, Marko J Spasojevic, Concepción L Alados, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 12, 2018
Correction: "Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 10 affected individuals"Kai Lee Yap, Amy E Knight Johnson, David Fischer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 17, 2018
Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 9 affected individualsKai Lee Yap, Amy E Knight Johnson, David Fischer, et al.
Pageof 6